Stay informed with the latest litigation news. Explore now

IP Verse

Apotex competitive analysis

Latest publications and patents of Apotex New

Explore the latest publications and patents granted to Apotex, showcasing their recent innovations and technological advancements.

Last updated on: Sep 8, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Apotex
EP1294379	Apr 1, 2009	A New Use For Deferiprone	Revoked

Latest patents of Apotex opposed by its competitors

Explore Apotex's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP1294379	Apr 1, 2009	A New Use For Deferiprone	2

Latest PTAB cases involving Apotex New

Discover the latest PTAB cases involving Apotex, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 14, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Apotex
IPR2025-00514	Jan 30, 2025	APOTEX	ALKERMES PHARMA IRELAND	Discretionary Denial
IPR2024-00631	Mar 1, 2024	APOTEX	NOVO NORDISK	Terminated-Settled
IPR2023-00512	Feb 10, 2023	APOTEX	CELGENE	Terminated-Settled
IPR2022-01524	Sep 9, 2022	APOTEX	REGENERON PHARMACEUTICALS	Institution Denied
IPR2022-00301	Dec 9, 2021	APOTEX	REGENERON PHARMACEUTICALS	Final Written Decision
IPR2022-00298	Dec 9, 2021	APOTEX	REGENERON PHARMACEUTICALS	Final Written Decision
IPR2021-01507	Sep 8, 2021	APOTEX	AUSPEX PHARMACEUTICALS	Institution Denied
IPR2021-01132	Jun 17, 2021	APOTEX	PFIZER	Terminated-Settled
IPR2019-00400	Dec 13, 2018	APOTEX	UCB BIOPHARMA	Final Written Decision
IPR2018-00685	Feb 23, 2018	APOTEX	CELGENE	Institution Denied

Top competitors of Apotex

Top competitors of Apotex based on patent oppositions.

LIPOMED